CN
264-190-9
应用筛选条件
关键词:'264-190-9'
显示 1-30 共 44 条结果 关于 "264-190-9" 范围 技术文档
XP725 Antibody Number-Lot Number 071M4826
212 233 234 235 236 257 258 259 260 281 282 283 284
3.6 213 214 215 216 237 238 239 240 261 262 263 264 285 286 287 288
4.1 289 290 291 292 313 314 315 316 337 338 339
Collagen solution from bovine skin (C2124)
. Grinnell, F., Fibroblast biology in three-dimensional
collagen matrices. Trends Cell Biol., 13, 264-269
(2003).
13. Heino, J., The collagen receptor integrins have
distinct ligand recognition and
Collagen Solution (C2249)
. Grinnell, F., Fibroblast biology in three-dimensional
collagen matrices. Trends Cell Biol., 13, 264-269
(2003).
13. Heino, J., The collagen receptor integrins have
distinct ligand recognition and
Collagen solution from bovine skin (C4243)
cells. Biol. Proced. Online, 7, 144-161 (2005).
9. Grinnell, F., Fibroblast biology in three-dimensional
collagen matrices. Trends Cell Biol., 13, 264-269
(2003).
10. Beningo, K.A. et al., Responses
Product Information Sheet - P6024
.
22. ibid., (1983). pp. 134, 163, 252, 294.
23. ibid., (1983). pp. 190, 210, 285, 407.
24. ibid., (1983). pp. 134, 144, 180, 190,
216, 222, 230, 252.
25. ibid., (1983). pp. 6, 216, 252, 330.
26
Protease and Phosphatase Inhibitor Cocktails Profiler
Sodium Othovanadate,
Sodium Pyrophosphate
(decahydrate),
ß-Glycerophosphate
1 ml
1 set
77
264
113
378
Phosphatase
Inhibitor Cocktail
Set IV
524628
Protection against alkaline
phosphatases
LABORATORY NOTEBOOK ISSUANCE PAGE
15
.9
99
18
.9
98
20
.1
80
4.
00
26
26
.9
82
28
.0
85
30
.9
74
32
.0
6
35
.4
5
39
.9
48
69
.7
23
72
.6
3
74
.9
Lab Notebook Guidelines
15
.9
99
18
.9
98
20
.1
80
4.
00
26
26
.9
82
28
.0
85
30
.9
74
32
.0
6
35
.4
5
39
.9
48
69
.7
23
72
.6
3
74
.9
LABORATORY NOTEBOOK ISSUANCE PAGE
15
.9
99
18
.9
98
20
.1
80
4.
00
26
26
.9
82
28
.0
85
30
.9
74
32
.0
6
35
.4
5
39
.9
48
69
.7
23
72
.6
3
74
.9
LABORATORY NOTEBOOK ISSUANCE PAGE
15
.9
99
18
.9
98
20
.1
80
4.
00
26
26
.9
82
28
.0
85
30
.9
74
32
.0
6
35
.4
5
39
.9
48
69
.7
23
72
.6
3
74
.9
Product Information Sheet - CS0720
phosphorylation in patient muscle
biopsies, lymphoblasts, and transmitochondrial
cell lines. Methods Enzymol., 264, 484-509
(1996).
4. Morgunov, I., and Srere, P.A., Interaction between
citrate synthase and malate
UV technologies in water purification systems
Smith, D.W. “Advanced technologies in water and wastewater treatment”. J. Environ. Eng. Sc., 1, 247-264, (2002).
2 Patrick, M.H.; Rahn, R.O. “Photochemistry and photobiology of nucleic acids”. S.-Y.
Apoptosis - Antibodies, Reagents and Kits
ELISA IC IH M IgG1 100 µL MAB3083 $190
(Calpain I or II), clone P1
Anti-Calpain I, large subunit (Calpain I), clone P-6 H WB ELISA IC IH M IgG1 100 µL MAB3082 $190
Anti-Calpain
Chrombook (WEB-Version)
trace analysis
04
9
LiChrospher® 100 RP-8 and RP-8 endcapped page 261
For reproducible reversed phase separation
LiChrospher® 60 RP-select B page 264
Excellent separations even with
Antibody Sourcebookﾙ Sixth Edition
Anti-Complement 5b-9 Rabbit pAb FS, IF, RID human, mouse 20490� 1 mg €242
Anti-Complement 9 Goat pAb IEP, RID human 204912 1 ml €80
Anti-b-COP (496-51�) Rabbit pAb IB, IC, IF mouse, rat PC175 100 µl €264
Katalog neoLab
cap jars . . . . 178, 257, 261, 264, 345
Screw caps . . . . 9, 172, 192, 196-197, 199,
203-205, 490, 494, 498, 501-502
Screw caps GL . . . . .
Calbiochem Biologics 30.2
. No. ST1042 50 µg € 190
Cat. No. ST1041 50 µl € 165
Cat. No. ST1046 100 µg € 361
Cat. No. ST1042 50 µg € 219
Cat. No. ST1046 100 µg €
Product Information Sheet-thificdnaro
reactions of 20 μl final volume each 03 003 230 001
1 kit, 480 reactions of 20 μl final volume each 12 239 264 001
High Pure RNA Tissue Kit 1 kit, 50 isolations 12 033 674 001
LightCycler® FastStart DNA
BRAND Katalog EN
166
Pumps, water jet filter 232
Pursept®-A
Disinfection spray 264
Disinfection tissues 264
Pursept®-AF
Disinfection concentrate 264
Q
Quality Management
(Information) 282
QuikSip™ BT-Aspirator
CoPrime®Biochromatography System
CoPrime™ ZS labels sheet NO 1 SPKCBS000LBL003
CoPrime™ Power supply 85–264 VAC, 48 VDC NO 1 SPKCBS20LELC001
CoPrime™ Power supply 85–264 VAC, 24 VDC NO 1 SPKCBS000ELC001
CoPrime™ PLC power supply 24 VDC, 5
Tools and Tips for Analyzing Apoptosis: A Kit Selection Guide
pAb
PC109 43 20/10 Reacts with ~42 kDa pro-caspase-4 human IB 100 ml €319
Anti-Caspase-6
(250-264) Rabbit pAb
218774 34 18/11 Reacts with 34 kDa pro and active
forms of caspase-6 .
bovine, canine
Biologics 32.3: NF-kB Activation: A Link Between Chronic Inflammation and Cancer
ED50 = 3-10 pg/ml as measured in a cell proliferation assay.
Purity: ≥97% by SDS-PAGE.
2 mg € 264
Interleukin-1β, Human, Recombinant, E. coli 407615 Biological activity: ED50 = 5 -10 pg/ml as measured
User Guide - Milli-Q® HX and HR 7000 Series
/544
Milli-Q® HX 7080 SD 106 / 234 125 / 275 256/564
Milli-Q® HX 7120 SD 114 / 251 133 / 293 264/582
Milli-Q® HX 7150 SD 126 / 278 145 / 320 276/608
Shipping Weight
Pharmacopoeia Monograph Methods
endcapped (5 μm) Hibar 150x4.6 mm 1.51455.0001
Injection: 5 μL
Detection: Shimadzu Prominence, UV 264 nm
Cell: 10 μL
Flow Rate: 1.5 mL/min
Mobile Phase: Solution A: Dissolve 9.1 g of potassium dihydrogen
Pharmacopoeia Monograph Methods - HPLC and UHPLC methods for Regulated Drug Analysis
endcapped (5 μm) Hibar 150x4.6 mm 1.51455.0001
Injection: 5 μL
Detection: Shimadzu Prominence, UV 264 nm
Cell: 10 μL
Flow Rate: 1.5 mL/min
Mobile Phase: Solution A: Dissolve 9.1 g of potassium dihydrogen
Application Notes Pharmacopoeia Monograph Methods
endcapped (5 μm) Hibar 150x4.6 mm 1.51455.0001
Injection: 5 μL
Detection: Shimadzu Prominence, UV 264 nm
Cell: 10 μL
Flow Rate: 1.5 mL/min
Mobile Phase: Solution A: Dissolve 9.1 g of potassium dihydrogen
Pharmacopoeia Monograph Methods HPLC and UHPLC columns for Regulated Drug Analysis
endcapped (5 μm) Hibar 150x4.6 mm 1.51455.0001
Injection: 5 μL
Detection: Shimadzu Prominence, UV 264 nm
Cell: 10 μL
Flow Rate: 1.5 mL/min
Mobile Phase: Solution A: Dissolve 9.1 g of potassium dihydrogen
MAPK: Antibodies, Proteins, Kits, siRNA and Reagents
SKK1-v2 RNAi 5 µg 62-263
siRNA plasmid, pKD-MKK4/SKK1-v4 RNAi 5 µg 62-264
siRNA plasmid, pKD-MKK4/SKK1-v4 RNAi 5 µg 62-264
siRNA plasmid, pKD-MKK4/SKK1-v2 RNAi 5 µg 62-263
MKK6
Antibody
XP725 Antibody List Lot 129K4831
D0188 NA NA P n/d n/d n/d
240 Anti Cy3+Cy5 C0992 NA NA M
251 Endothelial Cells E9653 NA NA M y n/d n/d
264 Anti Cy3+Cy5 C0992 NA NA M
277 Filamin F1888 NA NA M n/d n/d n/d
288 Anti Cy3+Cy5 C0992 NA
XP725 Antibody List Lot 129K4830
D0188 NA NA P n/d n/d n/d
240 Anti Cy3+Cy5 C0992 NA NA M
251 Endothelial Cells E9653 NA NA M y n/d n/d
264 Anti Cy3+Cy5 C0992 NA NA M
277 Filamin F1888 NA NA M n/d n/d n/d
288 Anti Cy3+Cy5 C0992 NA
1/2